PROF

Profound Medical Corp. NASDAQ Listed Oct 29, 2019

Healthcare ·Medical - Devices ·CA · profoundmedical.com

$7.16

After hrs $6.85 +0.00%

Mkt Cap $216.7M

52w Low $3.76 65.5% of range 52w High $8.95

50d MA $6.40 200d MA $6.22

P/E (TTM) 4.9x

EV/EBITDA -3.9x

P/B 2.3x

Debt/Equity 0.1x

ROE -64.1%

P/FCF -4.4x

RSI (14) —

ATR (14) —

Beta 0.47

50d MA $6.40

200d MA $6.22

Avg Volume 212.3K

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.

SIC Code

3841

CIK (SEC)

1628808

Phone

16474761350

2400 Skymark Avenue · Mississauga, ON L4W 5K5 · CA

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
May 7, 2026	AMC	-0.24	-0.19	+20.8%	—	—	—	—	—	—	—	—
Mar 5, 2026	AMC	-0.27	-0.27	+0.0%	7.49	-13.1%	-29.1%	-30.2%	-27.8%	-25.1%	-25.9%	—
Nov 13, 2025	AMC	-0.38	-0.26	+31.6%	6.35	-5.7%	+7.9%	+1.7%	-1.9%	-4.4%	-7.4%	—
Aug 14, 2025	AMC	-0.43	-0.52	-20.9%	5.54	-7.4%	-23.3%	-14.3%	-17.3%	-16.2%	-17.0%	—
May 8, 2025	AMC	-0.29	-0.36	-24.1%	4.98	-3.6%	-7.0%	-14.1%	-14.3%	-18.9%	-9.0%	—
Mar 6, 2025	AMC	-0.31	-0.20	+35.5%	7.29	+1.6%	-5.9%	-7.5%	-6.4%	-2.3%	-4.0%	—
Nov 7, 2024	AMC	-0.30	-0.38	-26.7%	8.96	+0.4%	-2.3%	-8.9%	-11.2%	-8.8%	-10.6%	—
Aug 8, 2024	AMC	-0.29	-0.28	+3.4%	9.62	-1.4%	-2.8%	-9.8%	-2.5%	-3.2%	-1.6%	—
May 9, 2024	AMC	-0.30	-0.26	+13.3%	8.52	+3.3%	-9.3%	-10.2%	-3.6%	+0.2%	-0.4%	—
Mar 7, 2024	AMC	-0.32	-0.42	-31.2%	9.02	-6.9%	-10.9%	-11.2%	-9.1%	-7.4%	-5.4%	—
Nov 2, 2023	AMC	-0.33	-0.26	+21.2%	9.16	+3.7%	+4.8%	+3.1%	+0.4%	+2.7%	+7.9%	—
Aug 9, 2023	AMC	-0.34	-0.35	-2.9%	10.43	-0.5%	-3.0%	-6.7%	-7.6%	-7.3%	-15.2%	—
May 10, 2023	AMC	-0.34	-0.32	+5.9%	13.26	+4.4%	+3.4%	+4.3%	-4.4%	-2.6%	+2.3%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Jan 7	Lake Street	Maintains	Buy → Buy	—	$7.73	$7.78	+0.6%	+6.2%	+9.7%	+9.2%	+11.9%	+8.4%
Apr 23	Lake Street	Maintains	Buy → Buy	—	$4.67	$4.90	+4.9%	+0.4%	+1.1%	+1.9%	+1.5%	+4.7%
Jul 16	Stifel	Upgrade	Hold → Buy	—	$9.15	$9.99	+9.2%	+6.0%	+6.4%	+9.2%	+11.7%	+11.5%
Mar 11	Alliance Global Partners	Maintains	Buy → Buy	—	$8.04	$8.00	-0.5%	-0.4%	+2.0%	+3.9%	+6.1%	+6.0%
Mar 8	Stifel	Maintains	Hold → Hold	—	$9.02	$8.40	-6.9%	-10.9%	-11.2%	-9.1%	-7.4%	-5.4%
Jan 4	Alliance Global Partners	Maintains	Buy → Buy	—	$7.68	$7.92	+3.1%	-4.9%	-2.6%	-1.4%	-4.0%	-1.2%
Aug 4	Raymond James	Downgrade	Strong Buy → Outperform	—	$10.12	$10.09	-0.3%	-3.7%	-0.5%	+5.4%	+3.1%	+0.0%
May 11	Alliance Global Partners	Maintains	Buy → Buy	—	$13.26	$13.84	+4.4%	+3.4%	+4.3%	-4.4%	-2.6%	+2.3%
May 11	TD Cowen	Maintains	Outperform → Outperform	—	$13.26	$13.84	+4.4%	+3.4%	+4.3%	-4.4%	-2.6%	+2.3%
Mar 21	Jefferies	Downgrade	Buy → Equal Weight	—	$10.16	$9.90	-2.6%	-0.9%	-12.9%	-12.4%	-9.7%	-10.0%
Nov 4	Raymond James	Upgrade	Outperform → Strong Buy	—	$3.92	$4.06	+3.6%	+18.6%	+28.1%	+23.7%	+25.0%	+20.4%
Mar 7	Cowen & Co.	Maintains	Outperform → Outperform	—	$9.35	$9.33	-0.2%	-12.3%	-11.3%	-11.6%	-9.8%	-11.1%
Feb 22	Raymond James	Downgrade	Strong Buy → Outperform	—	$9.51	$8.95	-5.9%	+6.2%	+6.6%	+5.2%	+12.3%	+12.4%

Data updated apr 26, 2026 8:46pm · Source: massive.com